[The effects of intravenous infused magnesium on hemodynamics and renal water-sodium metabolism in patients with essential hypertension]. 1989

T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura

Mean arterial pressure (MAP), heart rate (HR), urine volume (UV), urinary excretion of sodium (UNaV), endogenous creatinine clearance (Ccr), fractional excretion of sodium (FENa) were measured before and after intravenous infusion of 10% magnesium sulfate (an initial dose: Mg 13.5 mg/m2.BSA/15 min; a maintenance dose: Mg 2.7 mg/m2.BSA/105 min) in 6 normotensive subjects (NT) and 12 mild-to-moderate essential hypertensives (EHT). Following magnesium infusion, serum magnesium concentration (s-Mg) increased and reached the level of about 1.8 times basal value. Significant increases of UV, UNaV and FENa in both NT and EHT, and a similar tendency of Ccr in EHT were observed, while no significant change in MAP nor HR was found in the two groups. The changes in UNaV (delta UNaV) were positively correlated with those in FENa (delta FENa) and a similar tendency was shown between delta UNaV and change in Ccr (delta Ccr) in all subjects. While there was no significant percentage change of s-Mg (% delta s-Mg) nor of Ccr (% delta Ccr), those of UNaV (% delta UNaV) and FENa (% delta FENa) were significantly greater in EHT. It is concluded from these findings that magnesium infusion produces diuresis and the natriuresis which might result from suppression of renal tubular reabsorption of sodium, without any change in systemic hemodynamics in NT and EHT. The pronounced natriuretic response to magnesium in EHT might contribute to the hypotensive mechanism of magnesium loading in EHT.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008278 Magnesium Sulfate A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083) Magnesium Sulfate, Heptahydrate,Heptahydrate Magnesium Sulfate,Sulfate, Magnesium
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014882 Water-Electrolyte Balance The balance of fluid in the BODY FLUID COMPARTMENTS; total BODY WATER; BLOOD VOLUME; EXTRACELLULAR SPACE; INTRACELLULAR SPACE, maintained by processes in the body that regulate the intake and excretion of WATER and ELECTROLYTES, particularly SODIUM and POTASSIUM. Fluid Balance,Electrolyte Balance,Balance, Electrolyte,Balance, Fluid,Balance, Water-Electrolyte,Water Electrolyte Balance

Related Publications

T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
September 1985, Journal of clinical hypertension,
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
March 1974, Arzneimittel-Forschung,
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
April 1958, Circulation,
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
January 1994, Journal of Tongji Medical University = Tong ji yi ke da xue xue bao,
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
March 1988, Kokyu to junkan. Respiration & circulation,
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
April 1995, Hypertension (Dallas, Tex. : 1979),
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
April 1993, Journal of clinical pharmacology,
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
July 1988, American journal of hypertension,
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
June 1989, Arzneimittel-Forschung,
T Ohtomo, and K Kikuchi, and H Komura, and A Nozawa, and T Hasegawa, and S Suzuki, and N Satoh, and T Takada, and O Iimura
January 1991, Clinical therapeutics,
Copied contents to your clipboard!